Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

1802.6 (Glytoucan)

Id:c9fa3688-d088-546f-bf1e-c52827f62dbe

Glytoucan:G58169YV

Results found

Linked to

	Label	Description
	1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G32673DL-GLYCOSEQ00002989 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G06216UH-GLYCOSEQ00161349 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 has canonical residue n-glycan b-d-glcpnac 2 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G18942RK-GLYCOSEQ00005552 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G22196LK-GLYCOSEQ00000008 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 has canonical residue n-glycan a-d-manp 4 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G89430VM-GLYCOSEQ00142874 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G06216UH-GLYCOSEQ00161351 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	1802.6 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000085 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G32673DL-GLYCOSEQ00002989 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G06216UH-GLYCOSEQ00161349 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000060 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has canonical residue n-glycan b-d-glcpnac 2

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G18942RK-GLYCOSEQ00005552 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G22196LK-GLYCOSEQ00000008 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has canonical residue n-glycan a-d-manp 4

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G89430VM-GLYCOSEQ00142874 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 has glycosequence GLYGEN.GLYCOSEQUENCE:G06216UH-GLYCOSEQ00161351 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

1802.6 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000085 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.